CHA [CHINA TELECOM] 6-K: (Original Filing)
[Page 1.1 Announcement regarding the poll results and payment of the final dividend in the annual general meeting held on May 20, 2010, dated May 20, 2011. A-1 2]
MR [Mindray Medical International] 6-K: Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China,
[Mindray Appoints Ms.Fannie Lin Fan Generalunsel SHENZHEN, China, May23, 2011 /PRNewswire viaMTEX/ Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Ms.Fannie Lin Fan Generalunsel of thempany. Ms.Fan will join Mindray in June2011, succeeding Mr.Tim Fitzpatrick, who will step down to pursue other]
SSW [Seaspan] 424B5: ABOUT THIS PROSPECTUS SUPPLEMENT This document is in
[ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is the prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying base prospectus, which gives more general information, some of which may not apply to this offering. Generally, when we refer to the prospectus, we are referring to both parts]
CHA [CHINA TELECOM] 6-K: Page 1.1 Announcement regarding the poll results and
[Page 1.1 Announcement regarding the poll results and payment of the final dividend in the annual general meeting held on May 20, 2010, dated May 20, 2011. A-1 2]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011]
SSW [Seaspan] 6-K: (Original Filing)
[Item 1 Information Contained in this Form 6-K Report]
MCOX [Mecox Lane] 6-K: (Original Filing)
[MECOX LANE LIMITED Paul Bang Zhang Chief Financial Officer 2]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011]
SSW [Seaspan] 6-K: Item 1 Information Contained in this Form
[Item 1 Information Contained in this Form 6-K Report]
MCOX [Mecox Lane] 6-K: MECOX LANE LIMITED Paul Bang Zhang Chief Financial
[MECOX LANE LIMITED Paul Bang Zhang Chief Financial Officer 2]
